Catalyst Wire Dossier Catalyst Wire Dossier

Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine, covering 2026-03-27 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults [Phase 1]

See pricing